Search results
Results from the WOW.Com Content Network
The technology for ECMO is largely derived from cardiopulmonary bypass, which provides shorter-term support with arrested native circulation. The device used is a membrane oxygenator , also known as an artificial lung.
Cardiopulmonary bypass (CPB) or heart-lung machine, also called the pump or CPB pump, is a machine that temporarily takes over the function of the heart and lungs during open-heart surgery by maintaining the circulation of blood and oxygen throughout the body. [1] As such it is an extracorporeal device. CPB is operated by a perfusionist. The ...
Extracorporeal life support (ECLS) systems differ from traditional, theatre based, cardiac bypass machines in that they are portable and utilise percutaneous access as opposed to catheters which are surgically inserted into an open chest. The first access enters the femoral vein at the groin and is extended superiorly to the right atrium.
A MAQUET hollow fiber membrane oxygenator. A membrane oxygenator is a device used to add oxygen to, and remove carbon dioxide from the blood.It can be used in two principal modes: to imitate the function of the lungs in cardiopulmonary bypass (CPB), and to oxygenate blood in longer term life support, termed extracorporeal membrane oxygenation (ECMO).
However, oxygenators can also be utilized in extracorporeal membrane oxygenation in neonatal intensive care units by nurses. For most cardiac operations such as coronary artery bypass grafting, the cardiopulmonary bypass is performed using a heart-lung machine (or cardiopulmonary bypass machine).
Coronary artery bypass surgery aims to prevent death from coronary artery disease and improve quality of life by relieving angina, the associated feeling of chest pain. [1] The decision to perform surgery is informed by studies of CABG's efficacy in different patient subgroups, based on the lesions' anatomy or how well the heart is functioning.
An extracorporeal procedure is a medical procedure which is performed outside the body. Extracorporeal devices are the artificial organs that remain outside the body while treating a patient. Extracorporeal devices are useful in hemodialysis and cardiac surgery .
A phase 1 clinical trial is underway (as of August 2009), consisting of patients with coronary artery bypass grafting and patients in end-stage heart failure who have a left ventricular assist device. The trial involves testing a patch called Anginera which contains cells that secrete hormone-like growth factors stimulating other cells to grow.